Abivax SA (ABVX)
Euronext
98.10
-3.70 (-3.63%)
Closed
Aug 24, 2026
Day's Range
97.1599.65
52 wk Range
60.45139.00
Financial Statements - ABVX - Abivax SA
Revenue
0
Net Income
-336.10M▼ 90.7%
EBITDA
-268.98M▼ 62.6%
Free Cash Flow
-161.27M▼ 4.2%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods | - | - | - | 50.76M | 45.51M | 33.78M |
| Gross Profit | - | - | - | -50.76M | -45.51M | -33.78M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -246.05M | -172.98M | -127.37M | -51.20M | -41.39M | -38M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -31.71M | 2.67M | -7.65M | -2.82M | 2.42M | 200K |
| Pre Tax Income | -330.25M | -176.24M | -147.74M | -60.74M | -42.45M | -40.12M |
| Income Tax | 5.84M | 0 | 0 | 0 | 0 | -2.57M |
| Net Income | -336.10M | -176.24M | -147.74M | -60.74M | -42.45M | -37.55M |
| EPS Basic | -4.83 | -2.781468 | -3.43 | -3.18 | -2.75 | -2.62 |
| EPS Diluted | -4.83 | -2.781468 | -3.43 | -3.18 | -2.75 | -2.62 |
| Basic Shares Outstanding | 69.52M | 63.34M | 43.06M | 19.09M | 15.45M | 14.33M |
| Diluted Shares Outstanding | 69.52M | 63.34M | 43.06M | 19.09M | 15.45M | 14.33M |
| Ebit | -301.77M | -163.81M | -133.91M | -53.80M | -38.89M | -38.06M |
| Ebitda | -268.98M | -165.38M | -122.35M | -50.49M | -41.01M | -38.19M |
| Net Income Continuous Operations | -336.10M | -176.24M | -147.74M | -60.74M | -42.45M | -38M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
